TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 26.45
+0.15 (0.57%)
May 29, 2026, 1:55 PM CST
TWi Biotechnology Market Cap
TWi Biotechnology has a market cap or net worth of 2.92 billion as of May 29, 2026. Its market cap has increased by 201.78% in one year.
Market Cap
2.92B
Enterprise Value
2.66B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
26.45
Market Cap Chart
Since December 27, 2016, TWi Biotechnology's market cap has decreased from 3.83B to 2.92B, a decrease of -23.66%. That is a compound annual growth rate of -2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 2.92B | 61.61% |
| Dec 31, 2025 | 1.81B | 47.88% |
| Dec 31, 2024 | 1.22B | -0.52% |
| Dec 29, 2023 | 1.23B | 22.02% |
| Dec 30, 2022 | 1.01B | -7.50% |
| Dec 30, 2021 | 1.09B | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.23B |
| SYN-TECH Chem. & Pharm. | 3.20B |
| Shine-On BioMedical | 3.20B |
| Genovate Biotechnology | 3.03B |
| Chunghwa Chemical Synthesis & Biotech | 3.00B |
| Apex Biotechnology | 2.99B |
| HeXun Biosciences | 2.93B |
| GlycoNex Incorporation | 2.87B |